[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352836-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352836-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overexpression-of-tff3-is-associated-with-immune-infiltration-molecular-subtypes-and-clinical-progression-in-breast-cancer","Overexpression of TFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer","","Objective Trefoil factor 3 (TFF3) is a secreted protein implicated in mucosal protection and tumor progression, with an incompletely characterized role in breast cancer (BRCA). This study systematically assessed TFF3 expression patterns, clinical relevance, and prognostic value. Methods TCGA, GTEx, TNMplot, and TISCH2 data were integrated, with immunohistochemistry validation and analyses of survival, immune infiltration, and functional enrichment to define TFF3 biology. Results show links to hormone receptor positivity, luminal subtypes, early stage, diagnostics, immune modulation, and survival benefits. Conclusions TFF3 emerges as a biomarker and potential immunomodulator.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overexpression-of-tff3-is-associated-with-immune-infiltration-molecular-subtypes-and-clinical-progression-in-breast-cancer/352836/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overexpression-of-tff3-is-associated-with-immune-infiltration-molecular-subtypes-and-clinical-progression-in-breast-cancer/352836.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study on TFF3 in breast cancer?","Question",{"text":63,"@type":64},"The study aims to comprehensively evaluate TFF3 expression patterns, clinical relevance, and prognostic significance in BRCA.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were TFF3 expression and clinical associations analyzed?",{"text":68,"@type":64},"Integrated analyses used TCGA, GTEx, TNMplot, and TISCH2 databases, with immunohistochemistry validation in clinical samples and assessments including survival, immune infiltration, and functional enrichment.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical and immune-related findings are reported for high TFF3 expression?",{"text":72,"@type":64},"High TFF3 expression is associated with hormone receptor positivity, luminal A/B subtypes, early-stage disease, strong diagnostic discrimination between basal-like and non-basal-like BRCA, improved overall and disease-free survival, and immunomodulatory patterns linked to M2 macrophages and reduced cytotoxic immune signals.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352836,1790445862,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Current Medical Science (2026) 46:441–458  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1596-026-00173-0  \nOverexpression ofTFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer  \nBei Liu1 · Qin Wang1 · Rong‑fu Huang2 · Xiao‑hong Min1 · Han‑han Liu1 · Huan Wu1 · Hui Xu1 · Jun‑bo Hu1 · Yong‑qing Tong3 · Zi‑ming Huang4  \nReceived: 24 November 2025 / Revised: 8 February 2026 / Accepted: 10 February 2026 / Published online: 4 March 2026 © The Author(s) 2026  \nAbstract  \nObjective Trefoil factor 3 (TFF3), a secreted protein involved in mucosal protection and tumor progression, has an incompletely defined role in breast cancer (BRCA) . This study aimed to comprehensively evaluate TFF3 expression patterns, clinical relevance, and prognostic significance in BRCA.  \nMethods Data from the TCGA, GTEx, TNMplot, and TISCH2 databases were integrated to analyze TFF3 expression and clinical significance. Protein expression in clinical samples was validated via immunohistochemistry (IHC), and survival analysis, immune infiltration assessment, and functional enrichment analyses were performed to explore the biological role of TFF3 .  \nResults TFF3 was significantly upregulated in BRCA tumor tissues compared with normal tissues (P \u003C 0.001) and was expressed predominantly in malignant cells and tumor-associated macrophages. High TFF3 expression correlated strongly with hormone receptor (estrogen receptor/progesterone receptor) positivity, luminal A/B subtypes, and early-stage disease (P \u003C 0.01) and showed excellent diagnostic performance for distinguishing basal-like from non-basal-like BRCA (AUC = 0.95) . TFF3 was an independent protective factor: high expression was associated with improved overall survival (HR = 0.75, P = 0.02) and disease-free survival (P \u003C 0.001), especially in patients receiving hormone therapy (HR = 0.89, P = 0.0002) or chemotherapy (HR = 0.89, P = 0.0002). TFF3 exhibited immunomodulatory properties, correlated positively with M2 macrophages and negatively with cytotoxic immune cells (CD8+ T cells, NK cells) and checkpoint molecules (PD-1, CTLA-4) (P \u003C 0.01) . Functional analyses linked TFF3 to estrogen response pathways and cell cycle regulation. IHC validation confirmed TFF3 overexpression in 78.1% of tumors versus 23.9% of normal tissues (P \u003C 0.001), with the lowest expression in the basal-like subtype (8.33% vs. 59.2%, P = 0.0007) .  \nConclusions TFF3 is a robust diagnostic biomarker for BRCA molecular subtyping, an independent prognostic factor, and a potential immunomodulator. These findings highlight its clinical utility for patient stratification and potential as a therapeutic target, particularly in hormone receptor-positive BRCA.  \nKeywords TFF3 · Breast cancer · Immune microenvironment · Prognostic biomarker · Molecular subtyping  \nBei Liu, Qin Wang and Rong-fu Huang contributed equally to this work.  \n* Jun-bo Hu [cqjbhu@163.com](cqjbhu@163.com)  \n* Yong-qing Tong [tytsing@whu.edu.cn](tytsing@whu.edu.cn)  \n* Zi-ming Huang [huangziming@hbfy.com](huangziming@hbfy.com)  \n1 Department of Pathology, Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China  \n2 Department of Clinical Laboratory, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China  \n3 Prenatal Diagnostic Center of Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China  \n4 Department of Breast and Thyroid Surgery, Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China  \n1 Introduction  \nBreast cancer (BRCA) is one of the most prevalent malignancies worldwide. In 2020, an estimated 2.3 million new cases (11.7% of all cancers) were diagnosed worldwide, establishing that BRCA is the most commonly diagnosed cancer, surpassing the incidence of lung cancer. In the same year, 685,000 BRCA-related deaths were recorded, making it the fifth leading cause of cancer mortality [1] . Notably, epidemiological data reveal ","cbCaikp6OWA6inzJ","https://ap.wps.com/l/cbCaikp6OWA6inzJ","pdf",11022856,18,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Breast cancer epidemiology and classification\n## Tumor microenvironment and immune checkpoints","[{\"question\":\"What is the main objective of the study on TFF3 in breast cancer?\",\"answer\":\"The study aims to comprehensively evaluate TFF3 expression patterns, clinical relevance, and prognostic significance in BRCA.\"},{\"question\":\"How were TFF3 expression and clinical associations analyzed?\",\"answer\":\"Integrated analyses used TCGA, GTEx, TNMplot, and TISCH2 databases, with immunohistochemistry validation in clinical samples and assessments including survival, immune infiltration, and functional enrichment.\"},{\"question\":\"What clinical and immune-related findings are reported for high TFF3 expression?\",\"answer\":\"High TFF3 expression is associated with hormone receptor positivity, luminal A/B subtypes, early-stage disease, strong diagnostic discrimination between basal-like and non-basal-like BRCA, improved overall and disease-free survival, and immunomodulatory patterns linked to M2 macrophages and reduced cytotoxic immune signals.\"}]","Overexpression of TFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer | PDF",1790101639,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5c89bb43ac8535ff8bebea478dc31cd.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33c48b5b5c536fb27020d71bde02585e.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc5d47ef07e477316f475fddddd9c227.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5b3484df20287c67f0c7ffb499dded0.webp",980,1301]